Lingnuo (Shanghai) Pharmaceutical Technology Co.
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- Undisclosed
Investors
- 1
About Lingnuo (Shanghai) Pharmaceutical Technology Co.
, Ltd. operates as a drug technology developer that focuses on antibody treatment. The company established scientific advisory committee in April 2021. Zhaozhong Han the founder of the company. The core research team of the company has more than 20 members of its total employees. The company provides treatment of severe chronic diseases, such as severe inflammatory disease. The company focuses on macromolecule delivery technology and selective complement inhibition. The company's product pipeline includes LIN-2001 (recombinant protein), LIN-2002 (AAV gene therapy) and LIN-2003 (recombinant protein). The company's products include best-in-class (BIC) and first-in-class (FIC), such as complement targeted antibodies, recombinant protein drugs. The company’s revenue is generated by providing complement-targeted antibodies and recombinant protein drugs.
Who invested in Lingnuo (Shanghai) Pharmaceutical Technology Co.
1 investor across 1 round
See all investors in Lingnuo (Shanghai) Pharmaceutical Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 2, 2024
Amount
Undisclosed
Investors
Questions about Lingnuo (Shanghai) Pharmaceutical Technology Co.
Who invested in Lingnuo (Shanghai) Pharmaceutical Technology Co.?
Lingnuo (Shanghai) Pharmaceutical Technology Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lingnuo (Shanghai) Pharmaceutical Technology Co. raised?
Lingnuo (Shanghai) Pharmaceutical Technology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Lingnuo (Shanghai) Pharmaceutical Technology Co. last raise money?
Lingnuo (Shanghai) Pharmaceutical Technology Co.'s most recent round on record is a Series A, in Dec 2024.
What does Lingnuo (Shanghai) Pharmaceutical Technology Co. do?
Lingnuo (Shanghai) Pharmaceutical Technology Co. is a healthcare it company.
Where is Lingnuo (Shanghai) Pharmaceutical Technology Co. headquartered?
Lingnuo (Shanghai) Pharmaceutical Technology Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Lingnuo (Shanghai) Pharmaceutical Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at Lingnuo (Shanghai) Pharmaceutical Technology Co.'s stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Lingnuo (Shanghai) Pharmaceutical Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.